Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1233 results for "dr reddy"

Dr Reddy's Laboratories standalone net profit declines 88.51% ...

Sales decline 17.15% to Rs 2127.96 crore Net profit of Dr Reddy's Laboratories declined 88.51% to Rs 71.59 crore in the quarter ended December 2014 as against Rs 623.17 crore during the previous quarter ended December 2013. Sales declined 17.15% to Rs 2127.96 ... Business Standard, 1 hour ago

38 images for dr reddy

American Banking News, 15 hours ago
Sify, 5 hours ago
Ticker Report, 19 hours ago, 6 hours ago, 8 hours ago
Money Today, 2 weeks ago
Money Control, 4 hours ago
India Infoline, 8 hours ago, 5 hours ago
NDTV Profit, 7 hours ago
India Infoline

Dr. Reddy's ups revenues 9% in FQ3

How did this change your view of ? More Bullish More Bearish It Didn't This impact ( ) More Bullish More Bearish Unchanged Thanks for sharing your thoughts. Submit & View Results Skip to
 Seeking Alpha40 minutes ago Dr. Reddy's Q3 and 9 Months FY15 Financial Results  BusinessWeek6 hours ago ​Dr Reddy's Labs off day's high; Q3 PAT may decline 15%  Economic Times7 hours ago Results to watch for today! HDFC, IDFC, IIFL results among others  India Infoline13 hours ago

Sensex ends 123 points higher; Dr Reddy`s, HDFC Bank, BHEL rise

Sensex ends 123 points higher; Dr Reddy`s, HDFC Bank, BHEL rise Source: IRIS | 29 Jan, 2015, 04.05PM Indian equities ended the expiry session on a higher note with Sensex and Nifty at their new highs on Thursday. At the close, the benchmark 30-share index, ...
 Myiris2 hours ago Sensex upbeat, ends 245 points higher; metals, IT steal the show  Rediff.com1 month ago

Dr Reddy`s consolidated Q3 earnings drop 7% to Rs 5.75 bn

disclosed a marginal decline in consolidated net profit for the quarter ended December 2014. During the quarter, the profit of the company declined 7.11% to Rs 5,745.30 million from Rs 6,185.30 million in the same quarter previous year. Net sales for the ...
 Myiris2 hours ago
Money Control

Russia's impact not fully played out in Q3: Dr Reddy's

Dr Reddy's Laboratories beat street expectations on both topline and bottomline but operating performance was below estimates. Consolidated net profit of the drug maker fell 7 percent year-on-year to Rs 574.5 crore, impacted by weak operational performance ...
 Money Control4 hours ago Dr Reddy's net profit falls 7.09% in Q3  Business Today India5 hours ago Dr Reddy's Laboratories posts lower net profit at Rs. 575 cr in Q3  PharmaBiz6 hours ago Dr. Reddy's Q3 profit drops 7% on muted sales growth in the US  Livemint.com6 hours ago

Dr. Reddy's EPS of $0.53

How did this change your view of ? More Bullish More Bearish It Didn't This impact ( ) More Bullish More Bearish Unchanged Thanks for sharing your thoughts. Submit & View Results Skip to
 Seeking Alpha5 hours ago Dr. Reddy's Labs reports Q3 EPS 53c, compared to 57c a year ago  Market Pulse Navigator6 hours ago Pharmaceutical Newsletter - December 29, 2014 to January 02, 2015  India Infoline3 weeks ago Dr Reddy’s Labs plans to expand into domestic market: Report  India Infoline3 weeks ago

Active Pharmaceutical Ingredients (API) Market in India 2015-2019: Key Vendors are Aurobindo Pharma, Cipla and Dr. Reddy's Laboratories

Dublin, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( ) has announced the addition of the "Active Pharmaceutical Ingredients (API) Market in India 2015-2019" report to their ...
 Market Pulse Navigator4 hours ago India Active Pharmaceutical Ingredients (API) Market Report 2015-2019 with Aurobindo Pharma, Cipla & Dr. Reddy's Laboratories Dominating  Individual.com1 week ago Pharma shares in demand  India Infoline2 weeks ago Suggest to buy Dr. Reddy and Sun Pharma in the pharma sector: Mahantesh Sabarad  Economic Times2 months ago

Sensex, Nifty under pressure; Dr Reddy up 3%, SBI falls

Dr Reddy's Labs, Reliance, HDFC Bank, Hero MotoCorp and HUL are top gainers in the Sensex. Among the top losers are Coal India, HDFC, Bharti Airtel, SBI and ICICI Bank.
 Money Control8 hours ago Traders cautious on FO expiry, Nifty weak; Reliance up 3%  Money Control10 hours ago Epic Research Update : Reliance up 3%  Press Release Ping6 hours ago Sensex, Nifty volatile; Dr Reddy's Labs, DLF top gainers  Money Control2 months ago

Dr Reddy's Lab trims gains after weak Q3 earnings

Dr Reddy's Laboratories rose 1.91% to Rs 3,300 at 14:29 IST on BSE after consolidated net profit declined 7% to Rs 574.50 crore on 9% growth in revenues to Rs 3843.10 crore in Q3 December 2014 over Q3 December 2013. The Q3 result was announced ...
 Capital Market6 hours ago Dr Reddy's Lab gains after Q3 earnings  Business Standard7 hours ago Dr. Reddy's gains as arm inks pact to develop select cancer therapies  Arihant Capital6 days ago

Healthy performance drives up Dr Reddy's stock

In a docile market today, the stock of Dr Reddy's gained almost 4 per cent. This was thanks to the company's better-than-expected performance in the December quarter. On the high base of December 2013 quarter which saw the full benefit of several ...
 Hindu Business Line6 hours ago Stocks in news: Dr Reddy's, Zee Entertainment, Exide  Yahoo! India1 week ago Asia Pacific Market: Stocks fall on profit booking, weak offshore cues  Business Standard India56 minutes ago Today's Stock and Equity Market Trading News  Press Release Ping7 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - dr reddy
Get updated on latest news & your favorite topics right in your inbox!
More     Less